GlassScriptPhysician profile
Christopher J Darst
NPI 1275731531
$11,328.09
in general payments reported to CMS, 2019-2025
18 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what 92% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,947 · 2022: $1,430 · 2023: $175 · 2024: $479 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107 · Travel and Lodging: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.97 |
| Travel and Lodging | $844.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $9,248.99 | 2021-2022 | |
| Conetic Solutions, INC. | $737.32 | 2023-2025 | |
| Boston Scientific Corporation | $445.69 | 2023-2025 | General - Therapies, Emblem Mri S-Icd, Accolade Sr |
| Arthrex, INC. | $244.20 | 2025 | |
| Zimmer Biomet Holdings, INC. | $175.62 | 2021-2024 | Sternalock 360 System |
| Becton, Dickinson and Company | $123.31 | 2024-2025 | Arista Ah Flexitip, Arista |
| Medtronic, INC. | $61.11 | 2024 | Corevalve Evolut R |
| Smith+Nephew, INC. | $57.48 | 2023 | Renasys Go V2 Home, Pico |
| Abiomed | $46.31 | 2025 | |
| Abbott Laboratories | $34.37 | 2021-2025 | 2nd Gen Centrimag Primary Console |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.80 | 2023-2024 | Lifevest |
| Davol INC. | $23.15 | 2023 | |
| Edwards Lifesciences Corporation | $22.57 | 2023 | Hemosphere |
| Alnylam Pharmaceuticals INC. | $21.16 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $17.02 | 2024 | Arcalyst |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.47 | 2023 | Verquvo |
| Atricure, INC. | $14.34 | 2021 | |
| Cvrx, INC. | $14.18 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Darst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.